Form 4: Beta Bionics CEO Sells Shares for Tax Obligations
Insider Transaction Report
Beta Bionics President and CEO, Sean Saint, sold 3,359 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
Summary
- Sean Saint, President & CEO and Director of Beta Bionics, Inc. (BBNX), reported a sale of common stock.
- The transaction occurred on September 2, 2025.
- A total of 3,359 shares of common stock were sold.
- The weighted average sale price was $18.8632 per share, with prices ranging from $18.58 to $19.09.
- The sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following this transaction, Sean Saint beneficially owns 101,202 shares of Beta Bionics common stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine, tax-related sale of shares by an insider, which is generally considered neutral in terms of company sentiment. It does not reflect a change in the executive's confidence or the company's operational performance.
Future Outlook
NA
Industry Context
This is a routine insider transaction (Form 4) for tax purposes and does not provide specific insights into broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, tax-related sale of a relatively small number of shares by an insider, not indicative of a change in company fundamentals.
- Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.
Key Dates
| Date | Description |
|---|---|
| 09/02/2025 | Transaction Date for the sale of common stock. |
| 09/03/2025 | Signature Date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine, tax-related sale of shares by the President and CEO to cover withholding obligations from RSU vesting. Such transactions are common and typically pre-scheduled, not signaling a change in the company's fundamental outlook or the executive's long-term confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Beta Bionics, BBNX, Sean Saint, Insider Trading, Form 4, Stock Sale, CEO, Director, Restricted Stock Units, RSU, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.